BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8067753)

  • 1. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes.
    Grellier P; Valentin A; Millerioux V; Schrevel J; Rigomier D
    Antimicrob Agents Chemother; 1994 May; 38(5):1144-8. PubMed ID: 8067753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.
    Couto AS; Kimura EA; Peres VJ; Uhrig ML; Katzin AM
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):629-37. PubMed ID: 10417326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
    Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
    J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
    Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL
    Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.
    Cheng H; Rogers JD; Sweany AE; Dobrinska MR; Stein EA; Tate AC; Amin RD; Quan H
    Pharm Res; 1992 Dec; 9(12):1629-33. PubMed ID: 1488408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in in vitro cultures of Plasmodium falciparum and Babesia divergens by using serum-free medium based on human high density lipoproteins.
    Schrevel J; Grellier P; Rigomier D
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():71-5. PubMed ID: 1343728
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between docetaxel (Taxotere) and Plasmodium falciparum-infected erythrocytes.
    Schrével J; Sinou V; Grellier P; Frappier F; Guénard D; Potier P
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8472-6. PubMed ID: 7915841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types.
    van Vliet AK; van Thiel GC; Huisman RH; Moshage H; Yap SH; Cohen LH
    Biochim Biophys Acta; 1995 Jan; 1254(1):105-11. PubMed ID: 7811739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro.
    Zhang Y; Asante KS; Jung A
    J Parasitol; 1986 Dec; 72(6):830-6. PubMed ID: 3546655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells].
    Kunitama M; Komatsu N; Miura Y
    Rinsho Ketsueki; 1996 Nov; 37(11):1314-7. PubMed ID: 8960668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.
    Richier E; Biagini GA; Wein S; Boudou F; Bray PG; Ward SA; Precigout E; Calas M; Dubremetz JF; Vial HJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3381-8. PubMed ID: 17005821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.
    Saheki A; Terasaki T; Tamai I; Tsuji A
    Pharm Res; 1994 Feb; 11(2):305-11. PubMed ID: 8165193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.
    Tsuji A; Saheki A; Tamai I; Terasaki T
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.